Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Acq. announced
|
|
Panbela Therapeutics, Inc. (SNBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Cullen Michael T. reports a 3.3% stake in Panbela Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Cullen Michael T. reports a 6.3% stake in Panbela Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Cullen Michael T. reports a 8.2% stake in Panbela Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Schemel Donald Robert reports a 4.6% stake in Panbela Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Schemel Donald Robert reports a 6.2% stake in Sun BioPharma, Inc. |
| 02/14/2020 |
SC 13G/A
| Cullen Michael T. reports a 11.3% stake in Sun BioPharma, Inc. |
| 08/28/2019 |
SC 13G/A
| Ryan R. Gilbertson 2012 Irrevocable Trust reports a 10.1% stake in Sun BioPharma, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Cullen Michael T. reports a 11.1% stake in Sun BioPharma, Inc. |
| 02/14/2019 |
SC 13G/A
| Schemel Donald Robert reports a 7.9% stake in Sun BioPharma, Inc. |
| 02/14/2019 |
SC 13G/A
| Herron Paul M. reports a 4.6% stake in Sun BioPharma, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| POLINSKY DOUGLAS MICHAEL reports a 5.2% stake in Sun BioPharma, Inc. |
| 02/14/2017 |
SC 13G/A
| Cullen Michael T. reports a 13% stake in Sun BioPharma, Inc. |
| 02/14/2017 |
SC 13G/A
| Schemel Donald Robert reports a 11.8% stake in Sun BioPharma, Inc. |
|
|